119th Congress•House
HR. 1082
CommitteeShandra Eisenga Human Cell and Tissue Product Safety Act
Latest action
2025-06-24
Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Key actions
- Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
- Considered under suspension of the rules. (consideration: CR H2860-2862)
- Mr. Bilirakis moved to suspend the rules and pass the bill.
- On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H2860-2861)
- DEBATE - The House proceeded with forty minutes of debate on H.R. 1082.
- Motion to reconsider laid on the table Agreed to without objection.
- Placed on the Union Calendar, Calendar No. 127.
- Reported by the Committee on Energy and Commerce. H. Rept. 119-160.
- Reported by the Committee on Energy and Commerce. H. Rept. 119-160.
- Ordered to be Reported by Voice Vote.
- Committee Consideration and Mark-up Session Held
- Introduced in House
- Introduced in House
- Referred to the House Committee on Energy and Commerce.
Bill text versions
Related bills
Bill network
Current bill
HR. 1082
Shandra Eisenga Human Cell and Tissue Product Safety Act